Accumulating evidences suggest that the primary source of cardiac ROS production comes from nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, and that hyperglycemia directly augments the NADPH oxidases activities in the diabetic myocardium [11–14]. Here, FMO5 is linked to Hyperglycemia.